SAB1400065
Anti-CYP3A4 antibody produced in rabbit
IgG fraction of antiserum, buffered aqueous solution
别名:
Anti-CP33, Anti-CP34, Anti-CYP3A, Anti-CYP3A3, Anti-HLP, Anti-MGC126680, Anti-NF-25, Anti-P450C3, Anti-P450PCN1
选择尺寸
¥5,012.08
选择尺寸
About This Item
¥5,012.08
推荐产品
生物来源
rabbit
偶联物
unconjugated
抗体形式
IgG fraction of antiserum
抗体产品类型
primary antibodies
克隆
polyclonal
表单
buffered aqueous solution
种属反应性
human
技术
western blot: 1 μg/mL
UniProt登记号
运输
dry ice
1 of 4
此商品 | HPA066463 | SAB1410275 | HPA075539 |
---|---|---|---|
Quality Level 100 | Quality Level 100 | Quality Level 100 | Quality Level 100 |
antibody form IgG fraction of antiserum | antibody form affinity isolated antibody | antibody form purified immunoglobulin | antibody form affinity isolated antibody |
biological source rabbit | biological source rabbit | biological source rabbit | biological source rabbit |
conjugate unconjugated | conjugate unconjugated | conjugate unconjugated | conjugate unconjugated |
Gene Information human ... CYP3A4(1576) | Gene Information human ... CYP3A43(64816) | Gene Information human ... CYP3A7(1551) | Gene Information human ... CYP3A7(1551) |
technique(s) western blot: 1 μg/mL | technique(s) immunohistochemistry: 1:1000- 1:2500 | technique(s) western blot: 1 μg/mL | technique(s) immunofluorescence: 0.25-2 μg/mL (ICC-IF), western blot: 0.04-0.4 μg/mL |
一般描述
免疫原
Sequence
MALIPDLAMETWLLLAVSLVLLYLYGTHSHGLFKKLGIPGPTPLPFLGNILSYHKGFCMFDMECHKKYGKVWGFYDGQQPVLAITDPDMIKTVLVKECYSVFTNRRPFGPVGFMKSAISIAEDEEWKRLRSLLSPTFTSGKLKEMVPIIAQYGDVLVRNLRREAETGKPVTLKDVFGAYSMDVITSTSFGVNIDSLNNPQDPFVENTKKLLRFDFLDPFFLSITVFPFLIPILEVLNICVFPREVTNFLRKSVKRMKESRLEDTQKHRVDFLQLMIDSQNSKETESHKALSDLELVAQSIIFIFAGYETTSSVLSFIMYELATHPDVQQKLQEEIDAVLPNKAPPTYDTVLQMEYLDMVVNETLRLFPIAMRLERVCKKDVEINGMFIPKGVVVMIPSYALHRDPKYWTEPEKFLPERFSKKNKDNIDPYIYTPFGSGPRNCIGMRFALMNMKLALIRVLQNFSFKPCKETQIPLKLSLGGLLQPEKPVVLKVESRDGTVSGA
外形
免责声明
未找到合适的产品?
试试我们的产品选型工具.
储存分类代码
10 - Combustible liquids
闪点(°F)
Not applicable
闪点(°C)
Not applicable
法规信息
商品
一期生物转化反应在药物上引入或暴露官能团,目的是增加化合物的极性。尽管一期药物代谢发生在大多数组织中,但代谢的主要和首过部位发生在肝循环期间。
Phase I biotransformation reactions increase drug compound polarity, mainly occurring in hepatic circulation.
我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持